Form 4: Saba Capital Management Sells Shares of BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner and director, sold 16,663 shares of BlackRock Capital Allocation Term Trust (BCAT) at $13.92 per share on April 15, 2025.

Summary

• On April 15, 2025, Saba Capital Management, L.P., through Zachary Gindes, and Boaz Weinstein, sold 16,663 shares of BlackRock Capital Allocation Term Trust (BCAT).
• The shares were sold at a price of $13.92 per share.
• Following the transaction, Saba Capital Management, L.P. indirectly owns 11,792,868 shares of BCAT.

Sentiment

Score: 5

Explanation: Neutral sentiment as it simply reports a transaction. The sale itself doesn't necessarily indicate a positive or negative outlook, but rather a change in portfolio allocation.

Industry Context

This Form 4 filing indicates a change in ownership by a significant shareholder, Saba Capital Management, which is common in the investment management industry. These filings are closely watched by investors for insights into the perspectives of major stakeholders.

Stakeholder Impact

• The sale of shares by a major shareholder like Saba Capital Management could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold compared to their total holdings.

Key Dates

Keywords

Saba Capital Management, BlackRock Capital Allocation Term Trust, BCAT, share sale, Form 4, beneficial ownership, Boaz Weinstein, Zachary Gindes